Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 7Breast Neoplasms 7Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Recurrence 3Pancreatic Neoplasms 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Congenital Abnormalities 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2

Interventions

Cyclophosphamide 22Paclitaxel 12Epirubicin 12Doxorubicin 11Trastuzumab 10Docetaxel 10Carboplatin 10Taxes 7Bevacizumab 6pembrolizumab 5Radiotherapy 5Filgrastim 5Albumin-Bound Paclitaxel 5Neoadjuvant Therapy 4130-nm albumin-bound paclitaxel 4Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Lapatinib 3Granulocyte Colony-Stimulating Factor 3Fluorouracil 3Chemotherapy, Adjuvant 3sargramostim 2pertuzumab 2eribulin 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Cisplatin 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Inflammatory Breast Neoplasms × tipifarnib × Clear all
NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡